Healthcare >> Analyst Interviews >> January 9, 2006

OUTLOOK FOR MAJOR PHARMACEUTICALS: HERMAN SAFTLAS – STANDARD & POOR’S EQUITY GROUP

TWST: From your perspective, what are the key issues in the

pharmaceutical space at this point?

Mr. Saftlas: Before that, I want to say I am a Standard & Poor's Equity

Analyst and I have